Table 3.
Summary of demographic and clinical features of the 20 confirmed COVID-19 positive patients with abnormal findings on magnetic resonance imaging (MRI) of the brain.
| Demographic and clinical parameters | Patients with abnormal MRI head study (n=20) |
|---|---|
| Sex, M:F (%) | 13:7, (65:35) |
| Age (years), mean (range) | 59.7 (32–91) |
| Ethnicity | |
| White | 12 (60%) |
| Asian | 5 (25%) |
| Mixed | 1 (5%) |
| Not specified | 2 (10%) |
| Presenting symptoms at admission | |
| Shortness of breath | 16 (80%) |
| Fever | 9 (45%) |
| Cough and shortness of breath | 7 (35%) |
| Focal neurology | 2 (10%) |
| Fall | 1 (5%) |
| Presence of vascular risk factors | 17 (85%) |
| D-dimer level, mean (range) (normal range 0–250) |
6,795 (382–36,381) |
| Lymphocyte count (×109/l), mean (range) (normal range 0.7–4) |
0.74 (0.15–1.40) |
| Onset of neurological signs or symptoms from admission (days), mean (range) | 10.1 (1–39) |
| Outcome | |
| Full recovery/discharged | 7 (35%) |
| Requiring ongoing rehabilitation | 6 (30%) |
| Death | 4 (20%) |
| Slow clinical improvement | 3 (15%) |